EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A multi-omic landscape of steatosis-to-NASH progression

Liping Xiang, Xiaoyan Li, Yunchen Luo, Bing Zhou, Yuejun Liu, Yao Li iD, Duojiao Wu, Lijing Jia, Pei-Wu Zhu, Ming-Hua Zheng iD, Hua Wang, Yan Lu iD

Life Metabolism · 31.12.2022 · 1 (3) · 242-257

DOI: 10.1093/lifemeta/loac034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Metabolism, online erschienen am 01.12.2022. Verfasst von Liping Xiang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes M…. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Shanghai Municipal Science and Technology Committee.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nonalcoholic steatohepatitis (NASH) has emerged as a major cause of liver failure and hepatocellular carcinoma. Investigation into the molecular mechanisms that underlie steatosis-to-NASH progression is key to understanding the development of NASH pathophysiology. Here, we present comprehensive multi-omic profiles of preclinical animal models to identify genes, non-coding RNAs, proteins, and plasma metabolites involved in this progression. In particular, by transcriptomics analysis, we identified Growth Differentiation Factor 3 (GDF3) as a candidate noninvasive biomarker in NASH. Plasma GDF3 levels are associated with hepatic pathological features in patients with NASH, and differences in these levels provide a high diagnostic accuracy of NASH diagnosis (AUROC = 0.90; 95% confidence interval: 0.85−0.95) with a good sensitivity (90.7%) and specificity (86.4%). In addition, by developing integrated proteomic-metabolomic datasets and performing a subsequent pharmacological intervention in a mouse model of NASH, we show that ferroptosis may be a potential target to treat NASH. Moreover, by using competing endogenous RNAs network analysis, we found that several miRNAs, including miR-582-5p and miR-292a-3p, and lncRNAs, including XLOC-085738 and XLOC-041531, are associated with steatosis-to-NASH progression. Collectively, our data provide a valuable resource into the molecular characterization of NASH progression, leading to the novel insight that GDF3 may be a potential noninvasive diagnostic biomarker for NASH while further showing that ferroptosis is a therapeutic target for the disease.

Schlagwörter

Stichwörter der Autor:innen

GDF3ferroptosismulti-omicsnonalcoholic steatohepatitissimple steatosis

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao…
  • Key Laboratory of Metabolism and Molecular Medicine of the Ministry of Education, Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Department of Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Department of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Laboratory Animal Science, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhongshan Hospital Institute of Clinical Science, Fudan University, Shanghai Institute of Clinical Bioinformatics, Shanghai, China.

ORCID-Profile: Yao Li, Ming-Hua Zheng, Yan Lu

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Shanghai Municipal Science and Technology Committee
  • Excellent Youth Cultivation Program of Shanghai Sixth People’s Hospital
  • Shenzhen Science and technology R&D Foundation

Zitieren

APA

Xiang, L., Li, X., Luo, Y., Zhou, B., Liu, Y., Li, Y., Wu, D., Jia, L., Zhu, P. W., Zheng, M. H., Wang, H., & Lu, Y. (2022). A multi-omic landscape of steatosis-to-NASH progression. Life Metabolism, 1(3), 242-257. https://doi.org/10.1093/lifemeta/loac034

Vancouver

Xiang L, Li X, Luo Y, Zhou B, Liu Y, Li Y, et al. A multi-omic landscape of steatosis-to-NASH progression. Life Metabolism. 2022;1(3):242-257. doi:10.1093/lifemeta/loac034

BibTeX
@article{Xiang2022,
  author = {Xiang, Liping and Li, Xiaoyan and Luo, Yunchen and Zhou, Bing and Liu, Yuejun and Li, Yao and Wu, Duojiao and Jia, Lijing and Zhu, Pei-Wu and Zheng, Ming-Hua and Wang, Hua and Lu, Yan},
  title = {A multi-omic landscape of steatosis-to-NASH progression},
  journal = {Life Metabolism},
  year = {2022},
  volume = {1},
  number = {3},
  pages = {242--257},
  doi = {10.1093/lifemeta/loac034}
}
Kostenlos starten →